Compare Mutual Funds
Select a Mutual Fund
Risk | Very High | - |
Rating | - | - |
Min SIP Amount | ₹1000 | - |
Expense Ratio | 2.42 | - |
NAV | ₹14.80 | - |
Fund Started | 27 Jun 2023 | - |
Fund Size | ₹378.53 Cr | - |
Exit Load | Exit load of 1%, if redeemed within 15 days. | - |
Risk
Very High
-
Rating
-
-
Min SIP Amount
₹1000
-
Expense Ratio
2.42
-
NAV
₹14.80
-
Fund Started
27 Jun 2023
-
Fund Size
₹378.53 Cr
-
Exit Load
Exit load of 1%, if redeemed within 15 days.
-
1 Year | -4.69% | - |
3 Year | - | - |
5 Year | - | - |
1 Year
-4.69%
-
3 Year
-
-
5 Year
-
-
Equity | 95.72% | - |
Cash | -3.34% | - |
Equity
95.72%
-
Cash
-3.34%
-
Top 10 Holdings |
| - |
Top 10 Holdings
Cipla Ltd. | 9.77% |
SMS Pharmaceuticals Ltd. | 9.66% |
Sequent Scientific Ltd. | 8.72% |
Aster DM Healthcare Ltd. | 7.85% |
Zydus Wellness Ltd. | 7.30% |
Aurobindo Pharma Ltd. | 7.04% |
Pfizer Ltd. | 6.30% |
Alivus Life Sciences Ltd | 5.85% |
Adani Enterprises Ltd. | 5.72% |
Anthem Biosciences Ltd. | 5.59% |
-
Name | - | - |
Start Date | - | - |
Name
-
-
Start Date
-
-
Description | The scheme seeks to long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns. | - |
Launch Date | 27 Jun 2023 | - |
Description
The scheme seeks to long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.
-
Launch Date
27 Jun 2023
-